NCT06507878 Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.
| NCT ID | NCT06507878 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Thyroid Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 459 participants |
| Start Date | 2024-12-05 |
| Primary Completion | 2032-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 459 participants in total. It began in 2024-12-05 with a primary completion date of 2032-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical research study is to learn about the barriers in the real world to accessing treatments for ATC. And to learn about how patients with ATC tolerate and respond to the commercially available medications for treatment of this disease, outside of a clinical study.
Eligibility Criteria
Inclusion Criteria: All adult patients aged 18 years or older (with the exception of certain external participant countries where the legal adult age may be different; for example in Singapore, adult majors are defined by age 21 and older) with anaplastic thyroid cancer or poorly differentiated thyroid cancer as their clinical and/ or histological diagnosis will be included. Exclusion Criteria: Patients who do not have anaplastic thyroid cancer or poorly differentiated thyroid cancer on their tumor tissue would be excluded.
Contact & Investigator
Priyanka C Iyer, MBBS
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT06507878 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Thyroid Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06507878 currently recruiting?
Yes, NCT06507878 is actively recruiting participants. Contact the research team at piyer@mdanderson.org for enrollment information.
Where is the NCT06507878 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT06507878 clinical trial?
NCT06507878 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Priyanka C Iyer, MBBS at M.D. Anderson Cancer Center. The trial plans to enroll 459 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.